Sundyota Numandis is a new-age pharmaceutical company, leveraging its experience, expertise and energies to better people's lives.
Since its foundation in 2003, Sundyota Numandis has grown exponentially and has emerged as one of the fastest growing Indian pharmaceutical company, with a successful track record year after year.
Presently, with over 450 employees, we reach out to over 40,000 doctors and over 1,00,000 retail outlets across the country. Our current portfolio comprises of products in therapeutic segments like strain specific probiotics, immunobiotics, analgesics & anti-inflammatory, anti-arthritic, anti-ulcerants & digestive enzyme, iron & calcium supplements and anti-cold & anti-cough preparations.
Headquartered in Ahmedabad in western India and having a nation-wide presence, Sundyota Numandis is closely associated with leading, research based probiotic and nutraceuticals organizations of the globe. Leveraging these associations, we consistently offer innovative and technically superior product solutions. At present, we have the exclusive marketing rights of globally acclaimed, clinically proven molecules for prevention of diseases. We are strongly emerging as a premium Probiotic and Nutraceuticals House of India..
After having established ourselves as one of the most recognized pharmaceutical organizations in the country, we are expanding to multiply with the launch of our super-specialty divisions. With the advent of these divisions, our product portfolio expands into premium nutraceuticals products that are promoted to the medical fraternity with exclusive marketing rights. Our current and forthcoming nutraceuticals products are backed up by robust clinical data and patient testimonials. With this, our forte' strengthens in preventive medicines, rather than curative solutions..
With such product range and more such plans set up for future, we aim at achieving a group turnover of INR 500 Crores, within next three years.
For us, the journey has just begun and thus starts Sundyota Numandis era.